Bronchopulmonary Dysplasia
&nbsp;
Bronchopulmonary dysplasia (BPD) is a chronic respiratory disease that often occurs in low-weight or premature infants who have received supplemental oxygen or have spent long periods on a breathing machine (mechanical ventilation), such as infants with acute respiratory distress syndrome. BPD also occurs in older infants who experience abnormal lung development or those that have an antenatal infection or placental abnormalities (like preeclampsia) or chorioamnionitis.&nbsp;
&nbsp;
Bronchopulmonary Dysplasia Epidemiology Segmentation in the 7MM
&nbsp;
<ul>
<li class="ql-align-justify">Total Incident cases of Bronchopulmonary Dysplasia</li>
<li class="ql-align-justify">Weight-specific cases of Bronchopulmonary Dysplasia</li>
<li class="ql-align-justify">Severity-specific cases of Bronchopulmonary Dysplasia</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Bronchopulmonary Dysplasia Epidemiological Insights Observed in the 7MM</a>
&nbsp;
<ul>
<li class="ql-align-justify">The total incident cases of Bronchopulmonary Dysplasia observed in the 7MM were observed to be approximately 17K in the year 2021</li>
<li class="ql-align-justify">The highest diagnosed Bronchopulmonary Dysplasia population accounting for approximately 13.2K cases, was found in the United States in the year 2021. The total incident cases diagnosed in EU5 were found to be approximately 3.3K, whereas, in Japan, it was found to be 452 cases.</li>
<li class="ql-align-justify">The severity-specific Bronchopulmonary Dysplasia diagnosed cases observed in the United States were observed to be 5.2K (mild), 5.1K (moderate), and 2.8K (severe) in the year 2021.&nbsp;</li>
</ul>
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-market" target="_blank" rel="noopener noreferrer">Bronchopulmonary Dysplasia Market Insight</a>
&nbsp;
The market size of Bronchopulmonary Dysplasia in the 7MM was found to be approximately USD 0.028 million in 2021. &nbsp;
&nbsp;
Bronchopulmonary Dysplasia Market Strengths
&nbsp;
The understanding of Bronchopulmonary Dysplasia pathophysiology is improving rapidly due to exciting new technological advances in the research field and is opening avenues for pursuing therapeutic options in Bronchopulmonary Dysplasia.&nbsp;
&nbsp;
Bronchopulmonary Dysplasia Market Opportunities
&nbsp;
Refining existing models to better recapitulate pathological processes at play in affected infants to evaluate new candidate pharmacological interventions for BPD management.
&nbsp;
<a style="background-color: transparent; color: #1155cc;" href="https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-pipeline-insight" target="_blank" rel="noopener noreferrer">Bronchopulmonary Dysplasia Emerging Drugs</a>
&nbsp;
<ul>
<li class="ql-align-justify">The emerging drugs in the Bronchopulmonary Dysplasia market are</li>
<li class="ql-align-justify">OHB-607/TAK-607/SHP607 (Mecasermin Rinfabate): Takeda/Oak Hill Bio</li>
<li class="ql-align-justify">CHF5633: Chiesi Farmaceutici S.p.A.</li>
<li class="ql-align-justify">Pneumostem: Medipost</li>
<li class="ql-align-justify">AT-100: Airway Therapeutic</li>
<li class="ql-align-justify">Inhaled Nitric Oxide: Mallinckrodt/AdventHealth, and others</li>
</ul>
&nbsp;
Bronchopulmonary Dysplasia Key Players&nbsp;
&nbsp;
The key players working in the Bronchopulmonary Dysplasia market are
&nbsp;
<ul>
<li class="ql-align-justify">Gilead&nbsp;</li>
<li class="ql-align-justify">RedHill Bip-pharma</li>
<li class="ql-align-justify">AstraZeneca</li>
<li class="ql-align-justify">Johnsons &amp; Johnson Pharmaceuticals</li>
<li class="ql-align-justify">Bristol Myers Squibb, and others</li>
</ul>
&nbsp;

Bronchopulmonary Dysplasia Market

Bronchopulmonary Dysplasia Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape